QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.62 (+1.06%)
DIS   110.81 (+1.27%)
AMC   5.00 (+3.95%)
PFE   27.06 (+0.59%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Progyny (PGNY) Competitors

$34.65
-6.14 (-15.05%)
(As of 02/28/2024 ET)

PGNY vs. SHC, AGL, DVA, FMS, LNTH, AXSM, NVST, RARE, BHVN, and RYZB

Should you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Sotera Health (SHC), agilon health (AGL), DaVita (DVA), Fresenius Medical Care (FMS), Lantheus (LNTH), Axsome Therapeutics (AXSM), Envista (NVST), Ultragenyx Pharmaceutical (RARE), Biohaven (BHVN), and RayzeBio (RYZB). These companies are all part of the "medical" sector.

Progyny vs.

Progyny (NASDAQ:PGNY) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk.

94.9% of Progyny shares are owned by institutional investors. Comparatively, 88.9% of Sotera Health shares are owned by institutional investors. 14.0% of Progyny shares are owned by insiders. Comparatively, 65.1% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Progyny currently has a consensus target price of $48.30, indicating a potential upside of 39.39%. Sotera Health has a consensus target price of $20.67, indicating a potential upside of 38.24%. Given Progyny's stronger consensus rating and higher possible upside, analysts plainly believe Progyny is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sotera Health
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Progyny has higher earnings, but lower revenue than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Progyny$786.91M4.22$30.36M$0.5266.64
Sotera Health$1.00B4.21-$233.57M-$1.10-13.60

In the previous week, Progyny had 13 more articles in the media than Sotera Health. MarketBeat recorded 34 mentions for Progyny and 21 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.59 beat Progyny's score of 0.57 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Progyny
9 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive
Sotera Health
6 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Progyny received 40 more outperform votes than Sotera Health when rated by MarketBeat users. Likewise, 74.31% of users gave Progyny an outperform vote while only 54.67% of users gave Sotera Health an outperform vote.

CompanyUnderperformOutperform
ProgynyOutperform Votes
81
74.31%
Underperform Votes
28
25.69%
Sotera HealthOutperform Votes
41
54.67%
Underperform Votes
34
45.33%

Progyny has a net margin of 5.03% compared to Sotera Health's net margin of -30.99%. Sotera Health's return on equity of 53.66% beat Progyny's return on equity.

Company Net Margins Return on Equity Return on Assets
Progyny5.03% 11.64% 7.99%
Sotera Health -30.99%53.66%6.40%

Progyny has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 2.2, suggesting that its stock price is 120% more volatile than the S&P 500.

Summary

Progyny beats Sotera Health on 13 of the 18 factors compared between the two stocks.


Get Progyny News Delivered to You Automatically

Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PGNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PGNY vs. The Competition

MetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$3.32B$2.08B$4.96B$7.45B
Dividend YieldN/A2.11%2.90%3.88%
P/E Ratio66.6415.11226.4517.04
Price / Sales4.2231.603,028.7764.67
Price / Cash115.8820.7695.1154.63
Price / Book8.533.264.464.66
Net Income$30.36M$54.21M$112.67M$210.69M
7 Day Performance-14.02%-4.47%5.12%2.50%
1 Month Performance-8.07%-0.08%13.01%4.80%
1 Year Performance-7.75%-24.08%11.94%7.56%

Progyny Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Sotera Health
1.6301 of 5 stars
$16.25
-2.2%
$20.00
+23.1%
+1.0%$4.59B$1.00B-14.773,000Earnings Report
Analyst Upgrade
News Coverage
Gap Down
AGL
agilon health
1.9251 of 5 stars
$6.79
-4.5%
$19.25
+183.5%
-70.3%$2.76B$2.71B-30.86747Earnings Report
Analyst Report
News Coverage
Gap Down
Trading Halted
DVA
DaVita
3.8703 of 5 stars
$122.96
+0.6%
$111.33
-9.5%
+54.0%$10.78B$12.14B16.6270,000Insider Selling
Short Interest ↓
FMS
Fresenius Medical Care
4.3349 of 5 stars
$20.63
-2.3%
$24.00
+16.4%
-2.2%$12.10B$20.44B25.151,235Short Interest ↓
LNTH
Lantheus
4.79 of 5 stars
$56.83
-1.1%
$108.14
+90.3%
-6.0%$3.89B$935.06M39.74698Analyst Report
AXSM
Axsome Therapeutics
4.4239 of 5 stars
$81.14
-12.6%
$114.30
+40.9%
+31.1%$3.84B$50.04M-17.91502Analyst Report
High Trading Volume
NVST
Envista
4.7168 of 5 stars
$22.87
+1.5%
$30.78
+34.6%
-43.6%$3.92B$2.57B-37.4912,800Analyst Report
Short Interest ↓
Analyst Revision
RARE
Ultragenyx Pharmaceutical
4.4703 of 5 stars
$47.87
-2.1%
$90.11
+88.2%
+23.5%$3.93B$434.25M-5.751,311Analyst Report
BHVN
Biohaven
1.5018 of 5 stars
$47.24
-4.6%
$44.50
-5.8%
+213.0%$3.79B$462.51M-6.59202
RYZB
RayzeBio
0.5188 of 5 stars
$62.49
+0.1%
$31.33
-49.9%
N/A$3.74BN/A0.0088Upcoming Earnings

Related Companies and Tools

This page (NASDAQ:PGNY) was last updated on 2/28/2024 by MarketBeat.com Staff